Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

AAIM Guidelines for Interview and Post-Interview Communication for Graduate Medical Education Recruitment.

Alweis RL, Williams CM, Luther VP, Simmons DL, Kopelman R, Angus SV, Liao S, Nagalla S, Muchmore EA.

Am J Med. 2019 Sep;132(9):1106-1111. doi: 10.1016/j.amjmed.2019.05.023. Epub 2019 Jun 6. No abstract available.

PMID:
31175844
2.

Inappropriate Communication During Internal Medicine Fellowship Recruitment: A Mixed-Methods Analysis.

Williams CM, Alweis RL, O'Connor AB, Dalal B, Rai D, Abdullah A, Kopelman R, Cornett P, Frank MO, Luther VP, Muchmore EA.

Am J Med. 2019 Jun;132(6):770-775. doi: 10.1016/j.amjmed.2019.02.013. Epub 2019 Mar 7. No abstract available.

PMID:
30851262
3.

The American Society of Hematology and ASCO Curricular Milestones for Assessment of Fellows in Hematology/Oncology: Development, Reflection, and Next Steps.

Collichio F, Muchmore EA.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:887-893. doi: 10.1200/EDBK_201773. Review.

PMID:
30231329
4.

Internal medicine fellowship directors' perspectives on the quality and utility of letters conforming to residency program director letter of recommendation guidelines.

O'Connor AB, Williams CM, Dalal B, Sulistio MS, Roth TK, Milne CK, Collichio FA, Muchmore EA, Alweis R.

J Community Hosp Intern Med Perspect. 2018 Aug 23;8(4):173-176. doi: 10.1080/20009666.2018.1500424. eCollection 2018.

5.

Problematic communications during 2016 fellowship recruitment in internal medicine.

Cornett PA, Williams C, Alweis RL, McConville J, Frank M, Dalal B, Kopelman RI, Luther VP, O'connor AB, Muchmore EA.

J Community Hosp Intern Med Perspect. 2017 Oct 18;7(5):277-281. doi: 10.1080/20009666.2017.1381546. eCollection 2017.

6.

Prostate adenocarcinoma metastases to the testis and brain: case report and review of the literature.

Chang J, Kwan B, Panjwani N, Villanueva N, Diamond S, Wong-Sefidan I, Muchmore E.

Oxf Med Case Reports. 2017 Aug 10;2017(8):omx042. doi: 10.1093/omcr/omx042. eCollection 2017 Aug.

7.

Guidelines for a Standardized Fellowship Letter of Recommendation.

Alweis R, Collichio F, Milne CK, Dalal B, Williams CM, Sulistio MS, Roth TK, Muchmore EA.

Am J Med. 2017 May;130(5):606-611. doi: 10.1016/j.amjmed.2017.01.017. Epub 2017 Feb 9. No abstract available.

PMID:
28189466
8.

Primary Care Residents Improve Knowledge, Skills, Attitudes, and Practice After a Clinical Curriculum With a Hospice.

von Gunten CF, Mullan PB, Nelesen R, Garman K, McNeal H, Savoia M, Muchmore E, Ikeda T, Amundson S, McKennett M, Diamant J, Pepper P, Gray C, Weissman D.

Am J Hosp Palliat Care. 2017 Sep;34(8):713-720. doi: 10.1177/1049909116655767. Epub 2016 Jun 26.

PMID:
27353516
9.

Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance.

Collichio FA, Hess BJ, Muchmore EA, Duhigg L, Lipner RS, Haist S, Hawley JL, Morrison CA, Clayton CP, Raymond MJ, Kayoumi KM, Gitlin SD.

J Cancer Educ. 2017 Sep;32(3):647-654. doi: 10.1007/s13187-016-0993-6.

PMID:
26897634
10.

Delaying the Pediatric Fellowship Start Date to Improve Trainee Well-Being.

Mink R, Caputo G, Fried E, Hofkosh D, Le-Bucklin KV, McMillan J, Muchmore E, Pryor A, Vargo D, Bale J Jr.

J Pediatr. 2015 Aug;167(2):222-3. doi: 10.1016/j.jpeds.2015.04.056. No abstract available.

PMID:
26210834
11.

Adoption of a Uniform Start Date for Internal Medicine Fellowships and Other Advanced Training: An AAIM White Paper.

Barrett JC, Alweis R, Frank M, O'Connor A, McConville JF, Adams ND, Arfons L, Bernard S, Bradley T, Buckley JD, Cohen E, Cornett P, Elkins S, Kopelman R, Luther VP, Petrusky J, McNeill DB, Omar B, Palapiano N, Roth T, Satko S, Fried ED, Muchmore EA.

Am J Med. 2015 Sep;128(9):1039-43. doi: 10.1016/j.amjmed.2015.05.024. Epub 2015 Jun 10. No abstract available.

12.

The Next Accreditation System: a strategy for implementing new reporting standards using a Hematology/Oncology model.

Collichio F, Kayoumi K, Sierra L, Clayton CP, Raymond M, Muchmore EA.

Am J Med. 2015 Feb;128(2):200-7. doi: 10.1016/j.amjmed.2014.10.025. Epub 2014 Oct 30. No abstract available.

PMID:
25448172
13.

Studying the effects of ACGME duty hours limits on resident satisfaction: results from VA learners' perceptions survey.

Kashner TM, Henley SS, Golden RM, Byrne JM, Keitz SA, Cannon GW, Chang BK, Holland GJ, Aron DC, Muchmore EA, Wicker A, White H.

Acad Med. 2010 Jul;85(7):1130-9. doi: 10.1097/ACM.0b013e3181e1d7e3.

PMID:
20592508
14.

Measuring the intensity of resident supervision in the department of veterans affairs: the resident supervision index.

Byrne JM, Kashner M, Gilman SC, Aron DC, Cannon GW, Chang BK, Godleski L, Golden RM, Henley SS, Holland GJ, Kaminetzky CP, Keitz SA, Kirsh S, Muchmore EA, Wicker AB.

Acad Med. 2010 Jul;85(7):1171-81. doi: 10.1097/ACM.0b013e3181d5a954.

PMID:
20305532
15.

Measuring progressive independence with the resident supervision index: empirical approach.

Kashner TM, Byrne JM, Chang BK, Henley SS, Golden RM, Aron DC, Cannon GW, Gilman SC, Holland GJ, Kaminetzky CP, Keitz SA, Muchmore EA, Kashner TK, Wicker AB.

J Grad Med Educ. 2010 Mar;2(1):17-30. doi: 10.4300/1949-8357-2.1.17.

16.

Measuring progressive independence with the resident supervision index: theoretical approach.

Kashner TM, Byrne JM, Henley SS, Golden RM, Aron DC, Cannon GW, Chang BK, Gilman SC, Holland GJ, Kaminetzky CP, Keitz SA, Muchmore EA, Kashner TK, Wicker AB.

J Grad Med Educ. 2010 Mar;2(1):8-16. doi: 10.4300/JGME-D-09-00083.1.

17.

Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation.

Dosanjh A, Muchmore EA.

Open Respir Med J. 2009 May 18;3:79-84. doi: 10.2174/1874306400903010079.

18.

The chimpanzee model: contributions and considerations for studies of hepatitis B virus.

Gagneux P, Muchmore EA.

Methods Mol Med. 2004;96:289-318. No abstract available.

PMID:
14762278
19.

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid.

Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12045-50. Epub 2003 Oct 1.

20.

Intra- and interspecific variation in primate gene expression patterns.

Enard W, Khaitovich P, Klose J, Zöllner S, Heissig F, Giavalisco P, Nieselt-Struwe K, Muchmore E, Varki A, Ravid R, Doxiadis GM, Bontrop RE, Pääbo S.

Science. 2002 Apr 12;296(5566):340-3.

21.

Chimpanzee models for human disease and immunobiology.

Muchmore EA.

Immunol Rev. 2001 Oct;183:86-93. Review.

PMID:
11782249
22.

In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee.

Heijtink R, Paulij W, van Bergen P, van Roosmalen M, Rohm D, Eichentopf B, Muchmore E, de Man R, Osterhaus A.

J Gen Virol. 1999 Jun;80 ( Pt 6):1529-35.

PMID:
10374972
23.

The chimpanzee model : contributions and considerations elizabeth muchmore.

Muchmore E.

Methods Mol Med. 1999;19:577-88. doi: 10.1385/0-89603-521-2:577.

PMID:
21374398
24.

Genital infection of female chimpanzees with human immunodeficiency virus type 1.

Girard M, Mahoney J, Wei Q, van der Ryst E, Muchmore E, Barré-Sinoussi F, Fultz PN.

AIDS Res Hum Retroviruses. 1998 Oct 10;14(15):1357-67.

PMID:
9788677
25.

A structural difference between the cell surfaces of humans and the great apes.

Muchmore EA, Diaz S, Varki A.

Am J Phys Anthropol. 1998 Oct;107(2):187-98.

PMID:
9786333
26.

A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.

Chou HH, Takematsu H, Diaz S, Iber J, Nickerson E, Wright KL, Muchmore EA, Nelson DL, Warren ST, Varki A.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11751-6.

27.

Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines.

Coëffier E, Girard M, Barré-Sinoussi F, Meignier B, Muchmore E, Fultz PN, LeClerc C.

AIDS Res Hum Retroviruses. 1998 Aug 10;14(12):1023-34.

PMID:
9718117
28.

Detection of widespread hepatocyte infection in chronic hepatitis C.

Agnello V, Abel G, Knight GB, Muchmore E.

Hepatology. 1998 Aug;28(2):573-84.

PMID:
9696027
29.
30.

Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase.

Grob PM, Cao Y, Muchmore E, Ho DD, Norris S, Pav JW, Shih CK, Adams J.

Nat Med. 1997 Jun;3(6):665-70.

PMID:
9176494
31.

Characterization and titration of an HIV type 1 subtype E chimpanzee challenge stock.

Barré-Sinoussi F, Georges-Courbot MC, Fultz PN, Nguyen Thi Tuyet H, Muchmore E, Saragosti S, Dubreuil G, Georges A, van der Ryst E, Girard M.

AIDS Res Hum Retroviruses. 1997 May 1;13(7):583-91.

PMID:
9135876
32.

Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1.

Huguenel ED, Cohn D, Dockum DP, Greve JM, Fournel MA, Hammond L, Irwin R, Mahoney J, McClelland A, Muchmore E, Ohlin AC, Scuderi P.

Am J Respir Crit Care Med. 1997 Apr;155(4):1206-10.

PMID:
9105055
33.

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain.

Girard M, Yue L, Barré-Sinoussi F, van der Ryst E, Meignier B, Muchmore E, Fultz PN.

J Virol. 1996 Nov;70(11):8229-33.

34.

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

Girard M, Meignier B, Barré-Sinoussi F, Kieny MP, Matthews T, Muchmore E, Nara PL, Wei Q, Rimsky L, Weinhold K, et al.

J Virol. 1995 Oct;69(10):6239-48.

35.

Permissiveness of Kupffer cells for simian immunodeficiency virus (SIV) and morphological changes in the liver of rhesus monkeys at different periods of SIV infection.

Persidsky Y, Steffan AM, Gendrault JL, Hurtrel B, Berger S, Royer C, Stutte HJ, Muchmore E, Aubertin AM, Kirn A.

Hepatology. 1995 May;21(5):1215-25.

PMID:
7737626
36.

Morphological changes in lymph nodes and expression of VCAM1 and cytokines at the late stages of SIV-induced disease in rhesus monkeys.

Persidsky Y, Steffan AM, Gendrault JL, Royer C, Beyer C, Muchmore E, Kirn A, Aubertin AM.

Res Virol. 1995 May-Jun;146(3):185-200.

PMID:
7481091
37.

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2755-9.

38.

Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.

Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M, Walker CM.

Princess Takamatsu Symp. 1995;25:227-35. Review.

PMID:
8875628
39.

Presence of virion protein x (Vpx) of simian immunodeficiency virus SIVmac 251 in target cells in vivo.

Persidsky Y, Liska V, Huss T, Gendrault JL, Venet A, Muchmore E, Traincard F, Kirn A, Aubertin AM.

J Med Primatol. 1995 Jan;24(1):35-42.

PMID:
7563009
40.

Sialylation and malignant potential in tumour cell glycosylation mutants.

Takano R, Muchmore E, Dennis JW.

Glycobiology. 1994 Oct;4(5):665-74.

PMID:
7881181
41.

Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.

Estaquier J, Idziorek T, de Bels F, Barré-Sinoussi F, Hurtrel B, Aubertin AM, Venet A, Mehtali M, Muchmore E, Michel P, Mouton Y, Girard M, Ameisen JC.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9431-5.

42.

Histochemical and immunohistochemical similarities between hepatic tumors in two chimpanzees and man.

Tabor E, Hsia CC, Muchmore E.

J Med Primatol. 1994 Jul;23(5):271-9. Erratum in: J Med Primatol 1996 Sep;23(7):413-4.

PMID:
7869355
45.

Methodological approaches to disinfection of human hepatitis B virus.

Prince DL, Prince HN, Thraenhart O, Muchmore E, Bonder E, Pugh J.

J Clin Microbiol. 1993 Dec;31(12):3296-304.

46.
47.

Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.

Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM.

J Immunol. 1993 Oct 15;151(8):4189-99.

PMID:
7691940
48.

A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.

Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S.

Virology. 1993 Jul;195(1):297-301.

PMID:
7686313
49.

Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability.

Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S.

Virology. 1992 Oct;190(2):894-9.

PMID:
1325713
50.

Developmental sialic acid modifications in rat organs.

Muchmore EA.

Glycobiology. 1992 Aug;2(4):337-43.

PMID:
1421755

Supplemental Content

Loading ...
Support Center